Big Pharma’s Deadly Covid Vaccine Monopoly

<p>A week ago,&nbsp;the Biden administration announced support for waiving intellectual property protection for Covid-19 vaccines. In response, Bio, a trade association representing biotechnology companies, issued a statement <a href="https://www.bio.org/press-release/support-trips-waiver-sets-dangerous-precedent" rel="noopener noreferrer" target="_blank">saying</a>, "The United States has unfortunately chosen to set a dangerous precedent with these actions.” This week on Intercepted: Intercept investigative journalists Sharon Lerner and Lee Fang discuss how the pharmaceutical industry has ruthlessly fought to maintain&nbsp;IP protection from the beginning of the pandemic despite global calls to share knowledge and know-how to end the crisis as quickly as possible. By claiming the same monopoly IP rights on Covid-19 therapeutics and vaccines as other drugs, the industry has perpetuated a market of scarcity and profiteering when a collaborative global response is needed.</p> &#10;&nbsp;<br /><hr><p style='color: grey; font - size: 0.75em; '>See <a style='color: grey; ' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.</p>